Actinium Pharmaceuticals (ATNM) Other Gross PP&E Adjustments (2021 - 2025)
Actinium Pharmaceuticals (ATNM) has disclosed Other Gross PP&E Adjustments for 5 consecutive years, with -$22000.0 as the latest value for Q3 2024.
- On a quarterly basis, Other Gross PP&E Adjustments rose 99.1% to -$22000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was -$22000.0, a 99.1% increase, with the full-year FY2023 number at -$1.9 million, down 339.46% from a year prior.
- Other Gross PP&E Adjustments was -$22000.0 for Q3 2024 at Actinium Pharmaceuticals, up from -$25000.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $773000.0 in Q4 2022 to a low of -$2.6 million in Q2 2023.
- A 4-year average of -$512400.0 and a median of -$99000.0 in 2021 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: soared 197.23% in 2022, then tumbled 60800.0% in 2023.
- Actinium Pharmaceuticals' Other Gross PP&E Adjustments stood at -$795000.0 in 2021, then skyrocketed by 197.23% to $773000.0 in 2022, then plummeted by 339.46% to -$1.9 million in 2023, then surged by 98.81% to -$22000.0 in 2024.
- Per Business Quant, the three most recent readings for ATNM's Other Gross PP&E Adjustments are -$22000.0 (Q3 2024), -$25000.0 (Q2 2024), and -$27000.0 (Q1 2024).